Hypoxia‐inducible factor 2α drives hepatosteatosis through the fatty acid translocase CD36

BACKGROUND & AIMS: Molecular mechanisms by which hypoxia might contribute to hepatosteatosis, the earliest stage in non‐alcoholic fatty liver disease (NAFLD) pathogenesis, remain still to be elucidated. We aimed to assess the impact of hypoxia‐inducible factor 2α (HIF2α) on the fatty acid transl...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Liver Int
Hoofdauteurs: Rey, Esther, Meléndez‐Rodríguez, Florinda, Marañón, Patricia, Gil‐Valle, Miriam, Carrasco, Almudena G., Torres‐Capelli, Mar, Chávez, Stephania, del Pozo‐Maroto, Elvira, Rodríguez de Cía, Javier, Aragonés, Julián, García‐Monzón, Carmelo, González‐Rodríguez, Águeda
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: John Wiley and Sons Inc. 2020
Onderwerpen:
Experimental Hepatology
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7539965/
https://ncbi.nlm.nih.gov/pubmed/32432822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/liv.14519
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items